No Data
No Data
Jiangxi Rimag Group Updates Its Capital Structure
Jiangxi Rimag Group Eyes Full Share Circulation
Yimaiyangguang (02522) plans to implement full circulation of listed in Hong Kong.
Sunac China Holdings Limited (02522) announced that the company's board of directors has reviewed and approved the implementation of full circulation (H-share full circulation) of 51.5621 million shares of unlisted shares held by several shareholders, which accounts for approximately 14.47% of the company's issued share capital as of the date of this announcement.
[IPO Monthly Report] The Hong Kong IPO market saw a surge in subscription popularity and a significant decrease in the rate of IPOs breaking below the issue price in June. The expectations of the "Big Four" were mixed with both sorrow and joy.
In the first half of 2024, Hong Kong's IPO market continued its recent sluggish trend due to external market factors, global economic uncertainty, and cautious investor sentiment. The "Big Four" lowered their forecast for Hong Kong's annual IPO fundraising at the beginning of the year, but PwC expects Hong Kong's new IPO fundraising to exceed HKD 100 billion this year. PwC stated that the reduction in bearish factors, high demand for funding for business development, and the end of the interest rate hike cycle will bring back funds from Europe, America, and the Middle East to Asia, which is beneficial for market liquidity and valuation improvement. After six months of market baptism, PwC finally gave in and lowered Hong Kong's...
Hong Kong stock market changes | Yimai Yangguang (02522) fell more than 8%, the stock price temporarily showed five consecutive declines. The company is a leading enterprise in the domestic medical imaging field.
Yimaiyangguang (02522) fell more than 8%, as of press time, it fell 8.13%, reporting HKD 16.5, with a turnover of HKD 1.4343 million.
Hong Kong stock anomaly | Yimaiyangguang (02522) plunged more than 20% in early trading and fell below the issue price. The company is a leading enterprise in the field of medical imaging in China.
In early trading, Yimai Yangguang (02522) plummeted by more than 20%, hitting a low of HK$14.5, once again falling below the issue price of HK$14.98. As of press time, it has fallen 18.18% to HK$15.12, with a turnover of HK$3.6319 million.
No Data